Search clinical trials for: AG-013736
Total 467 results
-
PfizerCompleted
-
University of Michigan Rogel Cancer CenterPfizerCompleted
-
PfizerCompletedColorectal NeoplasmsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia (CML) | Blast Phase Chronic Myelogenous Leukemia (CML) | Chronic Phase Phase Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)United States
-
Arog Pharmaceuticals, Inc.WithdrawnCarcinoma, Non-Small-Cell Lung
-
Institute of Cancer Research, United KingdomRoyal Marsden NHS Foundation Trust; PfizerCompletedClear-cell Metastatic Renal Cell CarcinomaUnited Kingdom
-
University of Wisconsin, MadisonPfizerCompletedNeoplasmsUnited States
-
PfizerCompletedCarcinoma, Renal CellJapan
-
National Taiwan University HospitalTaipei Veterans General Hospital, Taiwan; Tri-Service General HospitalCompletedHepatocellular CarcinomaTaiwan
-
PfizerCompleted
-
M.D. Anderson Cancer CenterPfizerCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustPfizer; Cancer Research UK; University of BirminghamCompletedSoft Tissue SarcomaUnited Kingdom
-
Lynkcell EuropeEnrolling by invitationBreast Cancer | Breast Neoplasms | Ovarian Neoplasms | Ovarian Cancer | HER2-positive Breast Cancer | HER2-negative Breast Cancer | HER-2 Protein Overexpression | BRCA MutationUkraine
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Adenoid Cystic Carcinoma | Progressive Disease | Recurrent Adenoid Cystic CarcinomaUnited States
-
PfizerCompletedKidney Neoplasms | Carcinoma, Renal CellUnited States
-
PfizerCompletedHealthy VolunteerSingapore
-
Columbia UniversityPfizerRecruitingPheochromocytoma | ParagangliomaUnited States
-
PfizerNo longer availableRenal Cell CarcinomaAustralia, Canada
-
University Health Network, TorontoPfizerCompletedHepatocellular CarcinomaCanada
-
PfizerCompletedMelanoma | Skin NeoplasmsUnited States, France
-
PfizerCompleted
-
National Cancer Institute (NCI)CompletedPheochromocytoma | ParagangliomaUnited States
-
PfizerCompletedThyroid NeoplasmsUnited States, Canada, Czech Republic, Poland, China, Italy, Spain, India, United Kingdom
-
PfizerCompletedAdvanced Solid TumorsUnited States
-
University of Michigan Rogel Cancer CenterCompletedHead and Neck Squamous Cell CarcinomaUnited States
-
PfizerCompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States
-
PfizerCompletedKidney NeoplasmsKorea, Republic of, United States, Canada, Spain, Italy, United Kingdom, China, Singapore, Slovakia, France, Japan, Australia, Germany, Taiwan, Brazil, Russian Federation, India, Poland, Austria, Greece, Ireland, Sweden
-
PfizerTerminatedMetastatic Renal Cell CarcinomaUnited States, Czechia
-
Children's Oncology GroupCompletedRefractory or Recurrent Solid Tumors, Excluding CNS TumorsUnited States, Canada
-
PfizerCompletedKidney NeoplasmsUnited States, China, Malaysia, India, Taiwan, Russian Federation, Mexico, Bosnia and Herzegovina, South Africa, Bulgaria, Chile, Philippines, Romania, Ukraine
-
Lynkcell EuropeAvailableKidney Cancer | Clear Cell Kidney Cancer | Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations
-
Memorial Sloan Kettering Cancer CenterPfizer; National Comprehensive Cancer NetworkCompletedAdenoid Cystic CarcinomaUnited States
-
Scottish Clinical Trials Research UnitPfizerCompletedRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Non-metastatic Renal Cell CarcinomaUnited Kingdom
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Comprehensive Cancer NetworkTerminatedRecurrent Melanoma | Stage IV Melanoma | Metastatic Intraocular Melanoma | Recurrent Intraocular Melanoma | Stage IV Intraocular Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Extraocular Extension Melanoma | Stage IIIA Intraocular Melanoma | Stage IIIB Intraocular Melanoma | Stage...United States
-
PfizerCompletedCarcinoma, Renal CellUnited States, France, Germany
-
PfizerCompletedHepatocellular CarcinomaFrance, Belgium, United States, Taiwan, Hong Kong, United Kingdom, Germany, Italy, China, Hungary, Japan, Slovakia, Korea, Republic of
-
University of CincinnatiPfizerTerminatedGlioblastoma MultiformeUnited States
-
National Cancer Institute (NCI)PfizerCompletedAdrenal Cortex NeoplasmsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingClear Cell Renal Cell Carcinoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage IV Renal Cell CancerUnited States
-
PrECOG, LLC.PfizerTerminatedRenal Cell CarcinomaUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Metastatic Clear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Recurrent Clear Cell Renal Cell CarcinomaUnited States
-
PfizerCompletedRenal Cell CancerUnited States, United Kingdom, Japan
-
University of California, IrvinePfizerCompletedMelanoma | Malignant Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC MelanomaUnited States
-
PfizerCompletedCarcinoma, HepatocellularJapan
-
PfizerTerminatedNon-Small Cell Lung Cancer | Urothelial CancerKorea, Republic of, United States, Taiwan, Poland, Spain, Russian Federation, Italy, Hungary
-
PfizerCompletedSolid TumorsUnited States, Taiwan, Japan, Korea, Republic of, Russian Federation, Hungary, France, Czechia, Germany, Italy, United Kingdom
-
PfizerCompletedBreast NeoplasmsUnited States, Canada, Czech Republic, Spain, Germany, Italy, India, United Kingdom